| mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.089 |
0.03 |
| mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.04 |
| mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.067 |
0.04 |
| mRNA |
SB 216763 |
GDSC1000 |
pan-cancer |
AAC |
-0.075 |
0.05 |
| mRNA |
GSK2126458 |
GDSC1000 |
pan-cancer |
AAC |
-0.062 |
0.05 |
| mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.05 |
| mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.05 |